NCT06419309

Brief Summary

Hashimoto's thyroiditis (HT) is the most common cause of chronic hypothyroidism in areas with sufficient iodine, stemming from an autoimmune response against thyroid peroxidase and/or thyroglobulin. It is the most prevalent autoimmune thyroid disease and a leading cause of overall hypothyroidism. Even when they reach euthyroidism, 82% of treated women with HT still have excess body weight, and 35% of them are obese. Thyroid dysfunction can affect the function of adipose tissue and lead to metabolic disturbances. Leptin can stimulate thyroid-stimulating hormone secretion, while thyroid-stimulating hormone can influence leptin release from adipose tissue. Additionally, HT patients often exhibit high levels of C-reactive protein and interleukin-6, suggesting an association between increased thyroid-stimulating hormone levels and the inflammatory process, which may contribute to comorbid disease risk in individuals with HT. Nutrition can serve as a complementary treatment for HT by affecting thyroid functions and having anti-inflammatory properties. Dietary interventions may involve eliminating gluten, lactose, or certain food components, or focusing on an anti-inflammatory dietary pattern while preventing nutritional deficiencies. Therefore, this study is a randomized controlled, single-blind trial designed to evaluate the effects of a gluten-free, lactose-free diet and a diet enriched with Aronia Melanocarpa, both individually and in combination, as well as healthy dietary protocols, on autoantibody levels, leptin, ghrelin, oxidative response, and weight loss in patients with Hashimoto's thyroiditis. The study aims to recruit a minimum of 80 participants aged 18-65 years, diagnosed with Hashimoto's thyroiditis at Istanbul Medical Faculty Hospital. In the initial face-to-face interview, participants will provide sociodemographic information, dietary habits, anthropometric measurements, and dietary intake records through a questionnaire. The study involves the inclusion of Aronia Melanocarpa in the diet (high anthocyanin content, 69.24 mg/100 ml), a gluten-free and lactose-free diet, both interventions being applied together, and the application of only healthy nutrition protocols to patients over an 8-week period, with serum assessments of thyroid-stimulating hormon, free T4, free T3, anti-thyroid peroxidase, anti-Tg, interleukin-6,anti tumor necrosis factor alpha, C-reactive protein and leptin-ghrelin levels at the beginning and end of the study. The goal is to create recommendations for patients, improve their quality of life, and establish sustainable nutritional interventions.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started May 2024

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

May 14, 2024

Completed
1 day until next milestone

Study Start

First participant enrolled

May 15, 2024

Completed
2 days until next milestone

First Posted

Study publicly available on registry

May 17, 2024

Completed
12 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 15, 2025

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

August 15, 2025

Completed
Last Updated

May 21, 2024

Status Verified

May 1, 2024

Enrollment Period

1 year

First QC Date

May 14, 2024

Last Update Submit

May 17, 2024

Conditions

Outcome Measures

Primary Outcomes (3)

  • Effect of diet on weight loss

    The effect of diets on weight loss will be evaluated. Body composition analyzes of individuals (body weight (kg), body fat ratio (%), body water ratio (%), visceral fat ratio) will be performed using handheld device.

    Start and end of study (8 weeks)

  • Effect of diet on hormone level

    The effects of diets on leptin and ghrelin levels will be examined with venous blood samples.

    Start and end of study (8 weeks)

  • Effect of diet on inflammatory parameters

    To evaluate oxidative stress parameters, two 5 mL venous blood samples will be taken from each patient in yellow tubes after an overnight fast of at least eight hours between 08:00 and 09:00 in the morning. The blood sample will be kept at room temperature for 10-20 minutes and after being centrifuged at 2000-3000 rpm for 20 minutes, it will be transferred to Eppendorf tubes with the help of a sterile pipette and will be stored in 2 separate refrigerators at -20 °C. IL-6, TNF-alpha, CRP levels will be measured with commercial kits, following the company protocol.

    Start and end of study (8 weeks)

Secondary Outcomes (1)

  • Effect of diet on routine hashimoto thyroid parameters

    Start and end of study (8 weeks)

Study Arms (4)

Gluten- lactose free diet

EXPERIMENTAL

People will be given a healthy diet by eliminating gluten-free lactose-containing foods from their diet. It will continue for 8 weeks.

Other: Dietary intervention

Aronia Melanocarpa added and Gluten- lactose free diet

EXPERIMENTAL

In addition to a healthy diet, people will be given aronia melanocarpa fruit juice daily (high in anthocyanins, 69.24 mg/100 mL cyanidin-3-glucoside) and a gluten-free-lactose-free diet.It will continue for 8 weeks.

Other: Dietary intervention

Aronia Melanocarpa added diet

EXPERIMENTAL

People will be given aronia melanocarpa fruit juice daily (high in anthocyanins, 69.24 mg/100 mL cyanidin-3-glucoside).It will continue for 8 weeks.

Other: Dietary intervention

Healthy eating group

EXPERIMENTAL

Healthy diet patterns with an average macronutrient content of 10-20% protein, 20-35% fat and 45-60% carbohydrate will be followed for 8 weeks.

Other: Dietary intervention

Interventions

Four different dietary interventions are planned. * Gluten-free, lactose-free diet, * Diet enriched with Aronia Melanocarpa, * Gluten-free, lactose-free and enriched with Aronia Melanocarpa diet, * Healthy diet

Aronia Melanocarpa added and Gluten- lactose free dietAronia Melanocarpa added dietGluten- lactose free dietHealthy eating group

Eligibility Criteria

Age18 Years - 65 Years
Sexfemale(Gender-based eligibility)
Gender Eligibility DetailsSince the prevalence of the disease is high in female individuals, it will be conducted with female individuals.
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Being diagnosed with Hashimoto's thyroiditis by a doctor,
  • Being a female individual between the ages of 18-65,
  • Not being diagnosed with any chronic disease that would negatively affect functioning other than Hashimoto's thyroid,
  • Not having used selenium and iodine supplements in the last month,
  • Individuals should not lose more than 4 kg of weight in the last month,
  • Not having been on a strict elimination diet for more than 4 months in the last year,
  • Not having applied any nutritional intervention during the last three months before the study.

You may not qualify if:

  • Pregnant or breastfeeding mother,
  • Individuals with chronic diseases,
  • Individuals allergic to red fruits

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Halic University

Istanbul, Turkey (Türkiye)

Location

MeSH Terms

Conditions

Hashimoto Disease

Interventions

Diet Therapy

Condition Hierarchy (Ancestors)

Thyroiditis, AutoimmuneThyroiditisThyroid DiseasesEndocrine System DiseasesAutoimmune DiseasesImmune System Diseases

Intervention Hierarchy (Ancestors)

Nutrition TherapyTherapeutics

Study Officials

  • Berrak Basturk, Lecturer

    Halic University

    PRINCIPAL INVESTIGATOR
  • Zeynep Ozerson, Assoc. prof.

    Halic University

    STUDY DIRECTOR
  • Ayse Kubat Uzum, Profesor

    Istanbul University

    STUDY DIRECTOR
  • Melike Cevikdizici, Nurse

    Istanbul University

    STUDY DIRECTOR
  • Yusuf Celik, Profesor

    Biruni University

    STUDY DIRECTOR

Central Study Contacts

Berrak Basturk, Lecturer

CONTACT

Ayse Kubat Uzum, Profesor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

May 14, 2024

First Posted

May 17, 2024

Study Start

May 15, 2024

Primary Completion

May 15, 2025

Study Completion

August 15, 2025

Last Updated

May 21, 2024

Record last verified: 2024-05

Locations